Matrix interference in ligand-binding assays: challenge or solution?

Measuring biotherapeutics with endogenous counterparts and pre-existing antibodies: an interferon case study

(2014) Heather Myler et al.   Bioanalysis

Due diligence in the characterization of matrix effects in a total IL-13 Singulex™ method

(2014) Stephanie Fraser et al.   Bioanalysis

Strategic approaches for assessment and minimization of matrix effect in ligand-binding assays

(2014) Judy Y Shih et al.   Bioanalysis

Evaluating the impact of matrix effects on biomarker assay sensitivity

(2014) Theingi Thway et al.   Bioanalysis

Addressing matrix effects in ligand-binding assays through the use of new reagents and technology

(2014) Shannon D Chilewski et al.   Bioanalysis

Orthogonal tools to help determine the required selectivity of ligand-binding assays in drug development

(2014) Jean W Lee   Bioanalysis

Matrix effect in ligand-binding assay: the importance of evaluating emerging technologies

(2014) Rebecca M Crisino et al.   Bioanalysis

An ultra-sensitive clinical biomarker assay: quantitation of thymus and activation-regulated chemokine in human plasma

(2014) Xuemei Zhao et al.   Bioanalysis

Challenges in selectivity, specificity and quantitation range of ligand-binding assays: case studies using a microfluidics platform

(2014) Tong-Yuan Yang et al.   Bioanalysis

Protein-based matrix interferences in ligand-binding assays

(2014) Boris Gorovits et al.   Bioanalysis

Resolution of matrix interference: quantitative and quasi-quantitative ligand-binding assays case studies

(2014) Franklin P Spriggs et al.   Bioanalysis

Immunogenicity and PK/PD evaluation in biotherapeutic drug development: scientific considerations for bioanalytical methods and data analysis

(2013) Yow-Ming C Wang et al.   Bioanalysis